Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Dr Arias is Deputy Head of Interventional Cardiology at the "Dr Ignacio Chavez" National Institute of Cardiology in Mexico City. His research interests include complex percutaneous coronary and structural heart interventions, cardiovascular technological innovation, TAVI, Alcohol Septal ablation, and paravalvular leak closure. He is a member of the national research system and the Mexican Society… View more
Job title: Interventional & Structural Cardiologist
Personal History Dr Liam McCormick is an Interventional Cardiologist at MonashHeart, Melbourne, Australia.1 Outside of work, he enjoys travelling, reading and keeping fit. He is an avid sports fan and has been a passionate supporter of the West Coast Eagles since their inception.1 Academic History Dr McCormick graduated from the University of Western Australia in 2002 with a… View more
Author(s): Mouhannad M Sadek , Robert D Schaller , Gregory E Supple , et al Added: 3 years ago
Scar-related reentrant ventricular tachycardia (VT) may be present in a variety of structural heart disease (SHD) phenotypes. In this setting, VT circuits are comprised of viable myocytes separated by fibrosis, allowing for the slow conduction needed to facilitate reentry.1,2 Aetiologies of fibrosis include ischaemic heart disease (IHD), inflammatory conditions, infiltrative cardiomyopathy,… View more
Author(s): Ethan J Rowin , Martin S Maron Added: 3 years ago
Hypertrophic cardiomyopathy (HCM), the most common genetic cardiomyopathy, is present in one in 500 of the general population and is caused by over 1,400 mutations in at least 11 genes encoding the cardiac sarcomere.1–4 Although the majority of patients with HCM remain asymptomatic with near-normal longevity, a small, but important, subset of patients are at increased risk for a wide range of… View more
Author(s): Eyal Nof , William G Stevenson , Roy John Added: 3 years ago
Sustained ventricular tachycardia (VT) and ventricular fibrillation (VF) are typically a manifestation of significant structural heart disease and often associated with a high risk of sudden cardiac death. Implantable cardioverter defibrillators (ICDs) remain the mainstay of therapy for prevention of sudden cardiac death associated with these arrhythmias.1 However, ICDs treat the arrhythmia after… View more